LodeHQ
AI news for people who shipFree, by email

India Business · Monday, 1 June 2026 · Issue 3 · 11 stories

Nvidia tops all Indian listed cos, FPIs shun IPOs

Markets & Indices

Companies & Earnings

Sun Pharma’s $11.75 bn Organon deal may overpay for a declining women's‑health business

Sun Pharma’s $11.75 bn all‑cash purchase of Organon makes it a top‑three player in women’s health and a major biosimilar contender, but the deal hinges on a segment that is already falling. Organon’s Q1 results showed a 19% drop in women’s‑health sales and a 28% plunge in its flagship contraceptive implant, raising doubts about the debt‑financed deal’s cash‑flow assumptions.

the-ken.com ↗2 min read at source

Adani Infra arm builds ₹50,000‑cr orderbook, plans EPC acquisitions

Adani Infra (India) Ltd, the promoter‑owned infrastructure unit of the Adani Group, has amassed an orderbook exceeding ₹50,000 crore and is projected to generate around ₹10,000 crore in annual revenue. Acting as a project‑management consultant for Adani’s ports, roads, airports and power projects, it is now eyeing acquisitions to bring EPC capabilities in‑house, having already bought Punj Lloyd and taken a stake in PSP Projects.

livemint.com ↗3 min read at source

Economy & Policy

Banking & Finance

Global Cues & Commodities

You’re caught up.

That was all 11 stories in the 1 June issue.